Showing promise in the field of obesity management, retatrutide presents a distinct method. Unlike many current medications, retatrutide works as a double agonist, at once engaging both glucagon-like peptide-1 (GLP-1) https://aishamdng290655.dreamyblogs.com/39041475/a-novel-retatrutide-the-glp-gip-binding-site-agonist